Institut Curie - site de Paris - Service d'Oncologie Médicale

Paris

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Cancer, Solid Tumors

Studies at this site

• Avelumab Program Rollover Study — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early